lorcainide has been researched along with Wolff-Parkinson-White Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brogden, RN; Eiriksson, Ce | 1 |
| Orning, OM | 1 |
| Bartáková, H; Hrobonová, V; Samánek, M | 2 |
| Jähnchen, E; Kasper, W; Meinertz, T; Pop, T; Treese, N | 1 |
| Lüderitz, B; Manz, M; Steinbeck, G | 1 |
| Jiang, H | 1 |
1 review(s) available for lorcainide and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Biological Availability; Clinical Trials as Topic; Drug Interactions; Electrophysiology; Half-Life; Hemodynamics; Humans; Kinetics; Piperidines; Wolff-Parkinson-White Syndrome | 1984 |
1 trial(s) available for lorcainide and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Biological Availability; Clinical Trials as Topic; Drug Interactions; Electrophysiology; Half-Life; Hemodynamics; Humans; Kinetics; Piperidines; Wolff-Parkinson-White Syndrome | 1984 |
6 other study(ies) available for lorcainide and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventricular Node; Benzeneacetamides; Encainide; Flecainide; Heart Atria; Humans; Lidocaine; Piperidines; Tachycardia; Tocainide; Wolff-Parkinson-White Syndrome | 1984 |
[Personal experience with the use of Lorcainide in the treatment of Wolff-Parkinson-White syndrome in infants and older children].
Topics: Adolescent; Anti-Arrhythmia Agents; Benzeneacetamides; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Male; Piperidines; Wolff-Parkinson-White Syndrome | 1983 |
Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzeneacetamides; Drug Evaluation; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Piperidines; Tachycardia; Wolff-Parkinson-White Syndrome | 1983 |
Electrophysiological effects of lorcainide in sinoatrial disease and in Wolff-Parkinson-White syndrome.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Benzeneacetamides; Cardiac Pacing, Artificial; Female; Heart Block; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Piperidines; Sinoatrial Block; Sinoatrial Node; Time Factors; Wolff-Parkinson-White Syndrome | 1982 |
[Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Benzeneacetamides; Child; Electrophysiology; Female; Heart Conduction System; Humans; Male; Middle Aged; Piperidines; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1990 |
Lorcainide treatment of Wolff-Parkinson-White syndrome in children and adolescents.
Topics: Adolescent; Anti-Arrhythmia Agents; Benzeneacetamides; Cardiac Complexes, Premature; Child; Child, Preschool; Electrocardiography; Female; Heart Conduction System; Humans; Infant; Infant, Newborn; Male; Piperidines; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1987 |